Skip to main content

Table 2 Prevalence of diabetes, IFG and normoglycemia in PURE Poland Study population in baseline, 3-year and 6-year follow-up

From: Changes in diabetes prevalence and corresponding risk factors - findings from 3- and 6-year follow-up of PURE Poland cohort study

 

Baseline

p-value

Follow-up 3

p-value

Follow-up 6

p-value

Diabetes prevalence

 Total

235 (17,67%)

 

319 (23,98%)

 

376 (28,27%)

 

 Female

133 (15,85%)

0.02

175 (20,86%)

< 0.01

204 (24,31%)

< 0.01

 Male

102 (20,77%)

144 (29,33%)

172 (35,03%)

 Urban

105 (12,68%)

< 0.01

150 (18,12%)

< 0.01

182 (21,98%)

< 0.01

 Rural

130 (25,9%)

169 (33,67%)

194 (38,65%)

IFG prevalence

 Total

345 (25.94%)

 

288 (21.65%)

 

229 (17.22%)

 

 Female

226 (26.94%)

> 0.05

157 (18.71%)

< 0.01

141 (16.81%)

> 0.05

 Male

119 (24.24%)

131 (26.68%)

88 (17.92%)

 Urban

186 (22.46%)

< 0.01

121 (14.61%)

< 0.01

124 (14.98%)

< 0.01

 Rural

159 (31.67%)

167 (33.07%)

105 (20.92%)

Normoglycemia prevalence

 Total

750 (56.39%)

 

723 (54.36%)

 

725 (54.51%)

 

 Female

480 (57.21%)

> 0.05

507 (60.43%)

< 0.01

494 (58.88%)

< 0.01

 Male

270 (54.99%)

216 (43.99%)

231 (47.05%)

 Urban

537 (64.86%)

< 0.01

557 (67.27%)

< 0.01

522 (63.04%)

< 0.01

 Rural

213 (42.43%)

166 (33.07%)

203 (40.44%)